Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin for Prevention of Postpartum Hemorrhage in Twin Deliveries
NCT07401524Phase 4Recruiting
- Sponsor
- Sheba Medical Center
- Start
- May 2026
- Primary completion
- Mar 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of carbetocin in postpartum hemorrhage (PPH), sponsored by Sheba Medical Center. Started May 2026; status: recruiting.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT07401524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07401524.